Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
MAIA Biotechnology, Inc. (MAIA) had Consolidated Net Income/Loss of $-4.52M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.52M |
|
-- |
|
-- |
|
$5.43M |
|
$-5.43M |
|
$0.91M |
|
$-4.52M |
|
$-4.52M |
|
$-4.52M |
|
$-4.52M |
|
|
Consolidated Net Income/Loss |
$-4.52M |
$-4.52M |
|
$-5.43M |
|
$-5.43M |
|
27.70M |
|
27.70M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$11.86M |
|
-- |
|
$0.00M |
|
$11.86M |
|
$5.06M |
|
-- |
|
$1.86M |
|
$6.92M |
|
$4.94M |
|
$4.94M |
|
$4.94M |
|
29.59M |
|
| Cash Flow Statement Financials | |
$-4.20M |
|
-- |
|
$5.46M |
|
$9.60M |
|
$10.86M |
|
$1.26M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.40% |
|
-91.40% |
|
-38.07% |
|
-91.40% |
|
$0.17 |
|
$-0.15 |
|
$-0.15 |
|